IGF2BP2 Regulates the Progression of Alzheimer's Disease Through m6A‐Mediated NLRP3 Inflammasome
ABSTRACT Background Recent studies show that N6‐methyladenosine (m6A) plays an important role in the pathogenesis of the Alzheimer's disease (AD), while the mechanisms involved were studied insufficiently. Aims The present study aimed to explore the effect of human insulin‐like growth factor 2...
Saved in:
Main Authors: | Wu Jingrui, Yang Haihui, Yan Jinjin, Fang Le |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2025-01-01
|
Series: | Immunity, Inflammation and Disease |
Subjects: | |
Online Access: | https://doi.org/10.1002/iid3.70121 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Arsenic inducible islet β-cell dysfunction and ferroptosis through m6A-YTHDF2-dependent CHAC1 enhancement
by: Tianming Qiu, et al.
Published: (2025-01-01) -
Pan-cancer characterization of m6A-mediated regulation of T cell exhaustion dynamics and clinical relevancies in human cancers
by: Weiping Ji, et al.
Published: (2025-03-01) -
NLRP3 Inflammasome-Mediated Osteoarthritis: The Role of Epigenetics
by: Yuzhou Liu, et al.
Published: (2025-01-01) -
Regulation of Shade Avoidance Under Low‐Blue‐Light by MTA in Soybean
by: Liya Zhang, et al.
Published: (2025-02-01) -
New insights into N6-methyladenosine in hepatocellular carcinoma immunotherapy
by: Mengran Li, et al.
Published: (2025-01-01)